This site uses cookies to ensure you get the best experience. Learn more

Sign up or log in to follow your favorite podcasts and listen to episodes!

Squawk on the Street’s Big Return to the New York Stock Exchange, NYSE President Stacey Cunningham Talks Reopening Plans and Meme Stocks, G-7 Countries' Global Minimum Corporate Tax Agreement, P.E. Firms' $34B Deal, Jack Dorsey's Bitcoin Message, Jeff Bezos' Summer Space Flight, No "Plus" for Musk, and an Exclusive With the CEO of Bristol Myers Squibb

Squawk on the Street
44min

Disclaimer: the content and artwork of this podcast are the property of its owner and are not affiliated with nor endorsed by jCasts.

A big morning for "Squawk on the Street" as Carl Quintanilla, Jim Cramer and David Faber mark the show's return to the New York Stock Exchange for the first time since March 2020, discussing what it means to be back at the "Big Board", how businesses are pushing to reopen and where the reopening trade fits into the picture. NYSE President Stacey Cunningham joined the program to talk about the exchange's reopening progress as well as the volatility in meme stocks. The anchors also reacted to the G-7 agreement to pursue the Biden Administration's idea of a global minimum corporate tax rate of at least 15 percent. On the M&A front, private equity firms Blackstone, Carlyle and Hellman & Friedman team up to acquire medical supply company Medline in a $34-billion leveraged buyout. Also in focus: Twitter & Square CEO Jack Dorsey making a bullish case for Bitcoin, Jeff Bezos' plan to join a Blue Origin space flight in July, Tesla cancels production of its Model S Plaid+ vehicle, and Biogen shares rise ahead of an FDA decision on whether to approve the company's Alzheimer's drug. Bristol Myers Squibb CEO Dr. Giovanni Caforio appeared on the program to discuss his company's cancer drug pipeline -- including the future for Opdivo which has experienced slower sales growth.